Elanco Animal Health ELAN
NYSE ELAN
$24.24 -0.26 (-1.06%)
At close: Aug 20, 2026 · 11:04 AM UTC

Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025)

Elanco Animal Health (ELAN) posted Accumulated Expenses of $206.0 million for Q4 2025, up 16.38% sequentially from $177.0 million in Q4 2024, and up 16.38% YoY from $177.0 million in Q4 2024.

Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025) Analysis & Trends

Elanco Animal Health has reported Accumulated Expenses for 9 years, with the latest figure at $206.0 million in Q4 2025.

  • Quarterly Accumulated Expenses rose 16.38% year-over-year to $206.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $206.0 million (up 16.38% YoY) and the FY2025 annual result came in at $206.0 million, up 16.38% from the prior year.
  • Accumulated Expenses improved to $206.0 million in Q4 2025 per ELAN's latest filing, from $177.0 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $206.0 million in Q4 2025 and troughed at $110.0 million in Q1 2023.
  • A 5-year average of $144.8 million and a median of $141.0 million in 2022 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2021 and 2022: Accumulated Expenses soared 116.78% in 2021, then dropped 21.08% in 2022.
  • Over 5 years, Accumulated Expenses stood at $185.0 million in 2021, then slipped by 21.08% to $146.0 million in 2022, then grew by 7.53% to $157.0 million in 2023, then increased by 12.74% to $177.0 million in 2024, then increased by 16.38% to $206.0 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $206.0 million, $177.0 million, and $157.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.85 Bn 42.88 Bn -
2 Teva Pharmaceutical Industries 43.31 Bn 39.66 Bn 2.15 Bn
3 Zoetis 31.65 Bn 29.98 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.18 Bn 19.52 Bn 683.80 Mn
6 Viatris 18.82 Bn 17.94 Bn 1.46 Bn
7 Neurocrine Biosciences 15.70 Bn 15.31 Bn 935.80 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 206.00 Mn
Dec 31, 2024 177.00 Mn
Dec 31, 2023 157.00 Mn
Mar 31, 2023 110.00 Mn
Dec 31, 2022 146.00 Mn
Sep 30, 2022 136.00 Mn
Jun 30, 2022 113.00 Mn
Mar 31, 2022 111.00 Mn
Dec 31, 2021 185.00 Mn
Sep 30, 2021 159.00 Mn
Jun 30, 2021 124.00 Mn
Mar 31, 2021 114.00 Mn
Dec 31, 2020 144.00 Mn
Sep 30, 2020 139.90 Mn
Jun 30, 2020 57.20 Mn
Mar 31, 2020 56.20 Mn
Dec 31, 2019 99.60 Mn
Sep 30, 2019 88.80 Mn
Jun 30, 2019 67.30 Mn
Mar 31, 2019 64.20 Mn